Imugene Begins Phase 1b/2 Clinical Trial of HER-Vaxx Vaccine for Stomach Cancer
News
The first patient has been dosed in a Phase 1b/2 trial evaluating Imugene’s stomach cancer vaccine HER-Vaxx. Researchers are still recruiting participants. They hope to enroll 18 patients at eight locations ... Read more